TADROS RAMY 4

What Happened
Ramy Tadros, President of U.S. Business at MetLife (MET), received 127 shares as an award/acquisition on 2026-06-09. The shares are recorded at $85.57 each for a total value of $10,867. This transaction is an award/deferred acquisition (code "A") tied to the MetLife Leadership Deferred Compensation Plan, not an open-market purchase.

Key Details

• Transaction date: 2026-06-09; filing date (Form 4): 2026-06-11.
• Price per share: $85.57; total value reported: $10,867.
• Transaction type: Award/Acquisition (A) — imputed reinvestment of dividends into deferred shares (see footnote).
• Footnote: Deferred shares represent shares that have become payable but whose receipt has been deferred under the MetLife Leadership Deferred Compensation Plan; reporting person rounds deferred shares to the nearest whole number (F1).
• Shares owned after transaction: not shown in the provided filing excerpt.
• Filing timeliness: Form 4 was filed two days after the transaction date (no late-filing flag provided).

Context
This was an internal deferred-compensation credit (reinvestment of dividends) rather than a market purchase or sale. Such awards reflect plan mechanics and tax/deferral elections and do not, by themselves, indicate a new cash investment or directional insider trading intent.